Oncolytic virus therapy in the elderly: immune frailty, challenges, and perspectives. [PDF]
Wang JW +4 more
europepmc +1 more source
Efficacy of Oncolytic Virus VV-GMCSF-Lact Against Immunocompetent Glioma. [PDF]
Ageenko A +10 more
europepmc +1 more source
Cancer genetics and response to oncolytic virus treatment for ovarian cancer. [PDF]
Fletcher EL, Cudmore AO, Vanderhyden BC.
europepmc +1 more source
Mechanisms of Oncolytic Virus-Induced Multi-Modal Cell Death and Therapeutic Prospects. [PDF]
Xu J, Liu C, An Y, Sun J, Wang S, Xia Q.
europepmc +1 more source
A Multi-Omics Dataset of Prostate Cancer Response to Oncolytic Virus OH2 Treatment. [PDF]
Xu J +6 more
europepmc +1 more source
Identification of TPRA1 as a Novel Receptor and Predictive Biomarker for Oncolytic Virus M1. [PDF]
Hu L +20 more
europepmc +1 more source
Enhanced oral nanomedicine utilizing biomineralized oncolytic virus for synergistic gastrointestinal cancer therapy. [PDF]
Hu Z +11 more
europepmc +1 more source
Phase 1 open-label study of ASP9801, an oncolytic virus, in patients with advanced or metastatic solid tumors. [PDF]
Villano JL +11 more
europepmc +1 more source
Opportunities, challenges, and future perspectives of oncolytic virus therapy for malignant melanoma. [PDF]
Wang JW, Feng Q, Liu JH, Xun JJ.
europepmc +1 more source
Cell Carriers for Oncolytic Virus Delivery: Prospects for Systemic Administration. [PDF]
Sarkisova VA +5 more
europepmc +1 more source

